Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of activated clotting time by blood sampling site during coronary angiography or PCI after unfractionated heparin
NL-OMON43038Withdrawn
- Sponsor
- Noordwest Ziekenhuisgroep
- Start
- Apr 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of heparin in coronary arteriosclerosis, sponsored by Noordwest Ziekenhuisgroep. Planned start Apr 2017; status: withdrawn.
02
Drugs
heparin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on NL-OMON43038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43038.